Access to genotypic resistance testing alters physician selection of antiretroviral therapy.
Publication
, Journal Article
Jones, S; Klotman, ME
Published in: Clinical Infectious Diseases
July 1, 2000
Duke Scholars
Published In
Clinical Infectious Diseases
ISSN
1058-4838
Publication Date
July 1, 2000
Volume
31
Issue
1
Start / End Page
275 / 275
Publisher
UNIV CHICAGO PRESS
Related Subject Headings
- Microbiology
- 11 Medical and Health Sciences
- 06 Biological Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jones, S., & Klotman, M. E. (2000). Access to genotypic resistance testing alters physician selection of antiretroviral therapy. Clinical Infectious Diseases, 31(1), 275–275.
Jones, S., and M. E. Klotman. “Access to genotypic resistance testing alters physician selection of antiretroviral therapy.” Clinical Infectious Diseases 31, no. 1 (July 1, 2000): 275–275.
Jones S, Klotman ME. Access to genotypic resistance testing alters physician selection of antiretroviral therapy. Clinical Infectious Diseases. 2000 Jul 1;31(1):275–275.
Jones, S., and M. E. Klotman. “Access to genotypic resistance testing alters physician selection of antiretroviral therapy.” Clinical Infectious Diseases, vol. 31, no. 1, UNIV CHICAGO PRESS, July 2000, pp. 275–275.
Jones S, Klotman ME. Access to genotypic resistance testing alters physician selection of antiretroviral therapy. Clinical Infectious Diseases. UNIV CHICAGO PRESS; 2000 Jul 1;31(1):275–275.
Published In
Clinical Infectious Diseases
ISSN
1058-4838
Publication Date
July 1, 2000
Volume
31
Issue
1
Start / End Page
275 / 275
Publisher
UNIV CHICAGO PRESS
Related Subject Headings
- Microbiology
- 11 Medical and Health Sciences
- 06 Biological Sciences